• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病关节炎中的代谢综合征及其组成部分

Metabolic Syndrome and Its Components in Psoriatic Arthritis.

作者信息

Aljohani Roaa

机构信息

Department of Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia.

出版信息

Open Access Rheumatol. 2022 Feb 17;14:7-16. doi: 10.2147/OARRR.S347797. eCollection 2022.

DOI:10.2147/OARRR.S347797
PMID:35210876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8860394/
Abstract

Psoriatic arthritis (PsA) is a well-known inflammatory disorder with a wide variety of phenotypes that extend beyond the joints. It has been defined as an immune-mediated disorder in which Th-1 and Th-17 cells play a key role. It has been associated with an elevated risk of metabolic syndrome (MetS), which is characterized by abdominal obesity, hypertension, hyperglycemia, and hyperlipidemia. While the exact pathophysiology of the link between PsA and MetS has yet to be precisely determined, persistence of inflammatory abnormalities, with overexpression of pro-inflammatory cytokines, might be the cause. Studies have consistently emphasized the strong association between elevated risk of developing cardiovascular disease and MetS in individuals with underlying PsA. The literature has also shown an association between the increased PsA severity and the increased frequency of MetS components. This association has important clinical consequences when treating patients with PsA. Therefore, screening programs should be implemented for PsA patients to evaluate whether they have MetS, and appropriate treatment should be given to manage cardiometabolic risk factors. Patients should also be closely monitored for potential adverse treatment effects on co-morbidities. This article summarizes the evidence of associations between several components of MetS and PsA and analyzes the impact of treatment on these factors.

摘要

银屑病关节炎(PsA)是一种众所周知的炎症性疾病,具有多种超出关节范围的表型。它被定义为一种免疫介导的疾病,其中Th-1和Th-17细胞起关键作用。它与代谢综合征(MetS)风险升高有关,代谢综合征的特征是腹部肥胖、高血压、高血糖和高脂血症。虽然PsA与MetS之间联系的确切病理生理学尚未精确确定,但炎症异常的持续存在以及促炎细胞因子的过度表达可能是原因。研究一直强调,患有潜在PsA的个体发生心血管疾病的风险升高与MetS之间存在密切关联。文献还表明,PsA严重程度增加与MetS各组分的频率增加之间存在关联。这种关联在治疗PsA患者时具有重要的临床意义。因此,应该为PsA患者实施筛查计划,以评估他们是否患有MetS,并应给予适当治疗以管理心脏代谢危险因素。还应密切监测患者治疗对合并症的潜在不良影响。本文总结了MetS的几个组分与PsA之间关联的证据,并分析了治疗对这些因素的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d1d/8860394/88b60572f067/OARRR-14-7-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d1d/8860394/88b60572f067/OARRR-14-7-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d1d/8860394/88b60572f067/OARRR-14-7-g0001.jpg

相似文献

1
Metabolic Syndrome and Its Components in Psoriatic Arthritis.银屑病关节炎中的代谢综合征及其组成部分
Open Access Rheumatol. 2022 Feb 17;14:7-16. doi: 10.2147/OARRR.S347797. eCollection 2022.
2
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy.代谢综合征与银屑病关节炎:减重作为一种改善病情治疗方法的作用。
Ther Adv Musculoskelet Dis. 2024 Aug 19;16:1759720X241271886. doi: 10.1177/1759720X241271886. eCollection 2024.
3
Metabolic Syndrome and psoriatic arthritis: considerations for the clinician.代谢综合征与银屑病关节炎:临床医生的相关考虑。
Expert Rev Clin Immunol. 2020 Apr;16(4):409-420. doi: 10.1080/1744666X.2020.1740593. Epub 2020 Apr 1.
4
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis.代谢综合征及其组成成分作为银屑病关节炎和类风湿关节炎中心血管危险因素的表现及影响有所不同。
J Clin Med. 2023 Jul 31;12(15):5031. doi: 10.3390/jcm12155031.
5
High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease.银屑病关节炎中代谢综合征和胰岛素抵抗的高患病率与潜在疾病的严重程度相关。
J Rheumatol. 2014 Jul;41(7):1357-65. doi: 10.3899/jrheum.140021. Epub 2014 Jun 15.
6
Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.系统评价和荟萃分析:银屑病关节炎、类风湿关节炎和银屑病患者代谢综合征的患病率。
Int J Rheum Dis. 2021 Sep;24(9):1112-1120. doi: 10.1111/1756-185X.14147. Epub 2021 Jun 2.
7
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review.银屑病关节炎及其与心脏代谢疾病的关联:一篇叙述性综述。
Ther Adv Musculoskelet Dis. 2021 Mar 2;13:1759720X21998279. doi: 10.1177/1759720X21998279. eCollection 2021.
8
Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?银屑病关节炎与代谢综合征:改善病情抗风湿药有作用吗?
Front Med (Lausanne). 2021 Aug 30;8:735150. doi: 10.3389/fmed.2021.735150. eCollection 2021.
9
Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?银屑病、银屑病关节炎和类风湿关节炎在代谢综合征和心血管危险因素方面是否存在差异?
Eur J Rheumatol. 2018 Oct 1;6(4):174-178. doi: 10.5152/eurjrheum.2019.19029. Print 2019 Oct.
10
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.慢性炎症性关节炎合并代谢综合征患者的临床特征和转归。
Intern Emerg Med. 2021 Jun;16(4):863-874. doi: 10.1007/s11739-020-02520-y. Epub 2020 Oct 20.

引用本文的文献

1
Validation of Turkish psoriatic arthritis screening tool for psoriatic arthritis: A cross-sectional comparative study.土耳其银屑病关节炎筛查工具对银屑病关节炎的验证:一项横断面比较研究。
Medicine (Baltimore). 2025 Aug 29;104(35):e44013. doi: 10.1097/MD.0000000000044013.
2
Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis.与普通人群、皮肤银屑病及其他炎性关节病相比,银屑病关节炎中代谢综合征及其组分的患病率:一项荟萃分析。
Clin Rheumatol. 2025 Aug 18. doi: 10.1007/s10067-025-07637-z.
3
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients.

本文引用的文献

1
Cardiovascular Safety of Biologics Targeting Interleukin (IL)-12 and/or IL-23: What Does the Evidence Say?靶向白细胞介素 (IL)-12 和/或 IL-23 的生物制剂的心血管安全性:证据表明了什么?
Am J Clin Dermatol. 2021 Sep;22(5):587-601. doi: 10.1007/s40257-021-00612-9. Epub 2021 Jul 22.
2
Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.系统评价和荟萃分析:银屑病关节炎、类风湿关节炎和银屑病患者代谢综合征的患病率。
Int J Rheum Dis. 2021 Sep;24(9):1112-1120. doi: 10.1111/1756-185X.14147. Epub 2021 Jun 2.
3
Prevalence of psoriasis in a cohort of children and adolescents with type 1 diabetes.
银屑病关节炎合并代谢综合征的患者表现出一种难以治疗的表型:这是仍未明确的患者亚组定义中的又一块拼图。
RMD Open. 2025 Jun 22;11(2):e005717. doi: 10.1136/rmdopen-2025-005717.
4
Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement-Monocentric Real-World Evidence.古塞库单抗治疗银屑病关节炎:对轴性和外周受累的治疗影响——单中心真实世界证据
J Clin Med. 2025 May 1;14(9):3151. doi: 10.3390/jcm14093151.
5
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis.银屑病关节炎中代谢综合征与疼痛灾难化之间的关系
Rheumatol Ther. 2025 Jun;12(3):581-592. doi: 10.1007/s40744-025-00758-6. Epub 2025 Mar 26.
6
The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort.胰岛素抵抗代谢评分可预测银屑病关节炎患者的心血管疾病风险:来自为期10年的前瞻性CARMA队列研究的结果
RMD Open. 2025 Mar 7;11(1):e005352. doi: 10.1136/rmdopen-2024-005352.
7
Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis.D型人格与社交抑制:银屑病关节炎中心血管风险及身体活动减少的驱动因素
Clin Rheumatol. 2025 Mar;44(3):1163-1171. doi: 10.1007/s10067-025-07312-3. Epub 2025 Jan 30.
8
Increase in comorbidities with age among patients with psoriatic arthritis: a multicenter observational study.银屑病关节炎患者共病随年龄增长情况:一项多中心观察性研究
Rheumatol Int. 2025 Jan 9;45(1):23. doi: 10.1007/s00296-024-05760-9.
9
Understanding the interplay between psoriatic arthritis and gout: "Psout".了解银屑病关节炎与痛风之间的相互作用:“Psout”。
Rheumatol Int. 2024 Dec;44(12):2699-2709. doi: 10.1007/s00296-024-05729-8. Epub 2024 Oct 23.
10
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world setting.在真实世界中,接受阿普斯特治疗的银屑病或银屑病关节炎患者的糖尿病和肥胖负担以及心脏代谢参数的改善情况。
JAAD Int. 2024 Mar 9;16:244-251. doi: 10.1016/j.jdin.2024.02.016. eCollection 2024 Sep.
1型糖尿病儿童和青少年队列中银屑病的患病率。
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e589-e591. doi: 10.1111/jdv.17318. Epub 2021 May 13.
4
Secukinumab efficacy in patients with PsA is not dependent on patients' body mass index.司库奇尤单抗在银屑病关节炎患者中的疗效不依赖于患者的体重指数。
Ann Rheum Dis. 2022 Mar;81(3):e42. doi: 10.1136/annrheumdis-2020-217251. Epub 2020 Mar 13.
5
A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates.一项针对银屑病与高血压之间关联并对协变量进行调整的系统评价和荟萃分析。
Medicine (Baltimore). 2020 Feb;99(9):e19303. doi: 10.1097/MD.0000000000019303.
6
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.类风湿关节炎的亚临床和临床动脉粥样硬化:来自 3 年、多中心、前瞻性、观察性 GIRRCS(意大利临床和实验风湿病研究组)研究的结果。
Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.
7
Obesity in psoriatic arthritis: Comparative prevalence and associated factors.银屑病关节炎中的肥胖:比较患病率及相关因素。
Medicine (Baltimore). 2019 Jul;98(28):e16400. doi: 10.1097/MD.0000000000016400.
8
Biomarkers of Inflammation in Obesity-Psoriatic Patients.肥胖症-银屑病患者的炎症生物标志物。
Mediators Inflamm. 2019 May 28;2019:7353420. doi: 10.1155/2019/7353420. eCollection 2019.
9
Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study.甲氨蝶呤对伴有代谢综合征的银屑病关节炎患者血糖影响的评估:一项初步研究。
Dermatol Reports. 2019 May 9;11(1):7965. doi: 10.4081/dr.2019.7965. eCollection 2019 Jan 23.
10
Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study.银屑病关节炎患者的心脏和心血管合并症:一项基于人群的病例对照研究。
Clin Rheumatol. 2019 Aug;38(8):2069-2075. doi: 10.1007/s10067-019-04528-y. Epub 2019 Apr 1.